3 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 7 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Unknown 2, Active not recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Isala: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery Nizaracianine Triflutate, Placebo Comparator - Injury of Ureter During Surgery (Disorder) | Phase 2 / Phase 3 | Recruiting | Curadel Surgical Innovations, Inc. | 336 | 2024-06-28 | 2026-02-23 |
| Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer S1 + Nal-IRI, Nal-IRI+Leucovorin+5-FU - Metastatic Pancreatic Cancer | Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 122 | 2019-12-01 | 2021-01-15 |
| Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis combined radiotherapy and MR-HIFU - Bone Metastases, Bone Neoplasm | Phase 1 / Phase 2 | Completed | UMC Utrecht | 10 | 2019-04-11 | 2024-02-07 |
| Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer Atezolizumab - Small-cell Lung Cancer | Phase 2 | Active not recruiting | Norwegian University of Science and Technology | 212 | 2018-07-31 | 2026-04-13 |
| Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide nivolumab-daratumumab, nivolumab-daratumumab with low-dose cyclophosphamide - Myeloma | Phase 2 | Completed | Amsterdam UMC, location VUmc | 62 | 2018-02-21 | 2024-05-22 |
| Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy Vemurafenib and Cobimetinib - Melanoma, Malignant, of Soft Parts | Phase 2 | Unknown | Radboud University Medical Center | 200 | 2017-01-27 | 2020-06-05 |
| HaemocomplettanĀ® P During Elective Complex Cardiac Surgery HaemocomplettanĀ® P, Human albumin (Placebo) - Fibrinogen Deficiency in Complex Cardiac Surgery | Phase 2 / Phase 3 | Completed | Isala | 120 | 2011-02-01 | 2014-12-16 |
Bone Neoplasms (1) · Hemostatic Disorders (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Pain (1) · Pancreatic Neoplasms (1) · Radiation Injuries (1) · Sarcoma, Clear Cell (1) · Small Cell Lung Carcinoma (1)
Albumins (1) · Cyclophosphamide (1) · Fibrinogen (1) · S 1 (combination) (1) · Serum Albumin, Human (1) · Sugars (1) · Vemurafenib (1) · ZW800-1 compound (1) · atezolizumab (1) · cobimetinib (1) · irinotecan sucrosofate (1)
Netherlands (7) · Denmark (1) · Lithuania (1) · Norway (1) · Sweden (1) · Switzerland (1) · United States (1)
Alexander L Vahrmeijer, M.D., Ph.D (1) · Arno P Nierich, MD, PhD. (1) · Helena M Verkooijen, MD, PhD (1) · J W Wilmink, MD, PhD (1) · John V Frangioni, M.D., Ph.D. (1) · Niels van de Donk, MD PhD (1)
PMID 28241354, PMID 34392637, PMID 41921365
2017 (1)